SAN JOSE, Calif., October 25, 2023 -- Ensurge Micropower (OSE: ENSU, and OTCQB:
ENMPY) ("Ensurge" or the "Company"), today announces it has signed an agreement
for its solid-state lithium microbattery technology that extends its growing
roster of strategic partnership engagements into the medical-device industry.
The solid-state lithium microbattery technology is being similarly evaluated by
six other manufacturers and the company remains on track to enter volume
production by the end of the year.
"This latest agreement with a leading Fortune 500 medical-device manufacturer
opens up yet another market opportunity for our unique battery technology," said
Lars Eikeland, CEO at Ensurge. "The agreement will also demonstrate how our
microbattery can help transform wearable or portable medical device design by
providing a safe, reliable and more energy-dense power source that has faster
charging and a more flexible form factor compared to today's alternatives. In
addition to these breakthrough capabilities and improved cycle life, our solid-
state lithium microbatteries will also be the first that can be assembled
directly onto a product's Printed Circuit Board using an industry-compatible
automated Surface Mount Technology (SMT) process."
About Ensurge Micropower
Ensurge is Energizing Innovation(TM) with the first ultrathin, flexible,
reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100
milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond.
The innovative Ensurge Microbattery enables energy-dense rechargeable products
that are ideal for form-factor-constrained applications including hearables
(hearing aids and wireless headphones), digital and health wearables, sports and
fitness devices, and IoT sensor solutions that use energy harvesting to power
everyday things. The company's state-of-the-art manufacturing facility, located
in the heart of Silicon Valley, combines patented process technology and
materials innovation with the scale of roll-to-roll production methods to bring
the advantages of Ensurge technology to established and expanding markets.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.